4599

antibody from Cell Signaling Technology, Inc

Targeting: MAP1LC3A ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3

Western blot (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

4599

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#4599, RRID:AB_10548192

Product name

LC3A (D50G8) XP® Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat

Host

Rabbit

Storage

-20°C

References

Submitted references

Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin.

Trzoss L, Fukuda T, Costa-Lotufo LV, Jimenez P, La Clair JJ, Fenical W
Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 14;111(41):14687-92

---

Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy.

Zhang MZ, Wang Y, Paueksakon P, Harris RC
Diabetes 2014 Jun;63(6):2063-72

---

Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3.

Sharifi-Sanjani M, Shoushtari AH, Quiroz M, Baust J, Sestito SF, Mosher M, Ross M, McTiernan CF, St Croix CM, Bilonick RA, Champion HC, Isenberg JS
Journal of the American Heart Association 2014 Jun 10;3(3):e000670

---

Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells.

Said A, Bock S, Lajqi T, Müller G, Weindl G
Journal of immunology (Baltimore, Md. : 1950) 2014 Dec 15;193(12):6135-43